Prostaglandins and other arachidonic acid metabolites in the kidney
- PMID: 3083150
- DOI: 10.1038/ki.1986.13
Prostaglandins and other arachidonic acid metabolites in the kidney
Abstract
This very brief summary of the various possible contributions of PG to normal and abnormal renal function should highlight the problem of assigning a specific role to PG in overall renal physiology and pathophysiology. PG produced in specific segments of the nephron will affect specific functions occurring in this segment. These effects need not necessarily be reflected in the overall renal function. Also in some cases, the determinant may not be prostaglandins, that is, cyclooxygenase derivatives of AA, but perhaps lipoxygenase or epoxygenase products that influence the functional parameters of the specific segment. Despite the multitude of renal functions that may be influenced by PG, we would like to propose a teleological hypothesis for an overall role of PG in the kidney, that is, that of cytoprotective agents. Renal vasodilatatory prostaglandins will maintain renal blood flow when the latter is challenged, thus, preventing hypoxic injury to the tissue. Endogenous prostaglandins may also protect tubular cells from extreme environmental changes as may occur on both the luminal and contraluminal sides. For example, tubular cells may be exposed to luminal fluid that may vary from hypotonic to hypertonic, from alkaline to acid, and so forth. Similarly, the interstitial fluid osmolality and solute composition is subject to considerable variations which may be opposite to those existing on the urinary side. The role of PG might be to maintain the internal milieu of the cells exposed to such extreme changes in environment. This could be accomplished by changing the permeability characteristics of the membranes and the function of pumps. Thus, specific PGs could dampen the hormonal response to protect the specific nephron segment, which might otherwise suffer injury. This hypothesis might also help to explain why the effect of PG administration or inhibition of PG synthesis may vary considerably depending on the overall physiological state of the subject: Maintenance of a local internal milieu may require different responses from those required for total body homeostasis.
Similar articles
-
Renal cyclo-oxygenase and lipoxygenase products in health and disease.Clin Physiol Biochem. 1984;2(2-3):91-100. Clin Physiol Biochem. 1984. PMID: 6435931 Review.
-
Eicosanoids in renal function.Prostaglandins Leukot Essent Fatty Acids. 1989 Jun;36(4):203-17. doi: 10.1016/0952-3278(89)90134-8. Prostaglandins Leukot Essent Fatty Acids. 1989. PMID: 2502777 Review.
-
[Arachidonic acid metabolites in the kidney].Nihon Rinsho. 1990 Jun;48(6):1166-74. Nihon Rinsho. 1990. PMID: 2117081 Japanese. No abstract available.
-
Physiology and pharmacology of prostaglandins.Dig Dis Sci. 1986 Feb;31(2 Suppl):6S-19S. doi: 10.1007/BF01309317. Dig Dis Sci. 1986. PMID: 3080290 Review.
-
Biochemistry and pharmacology of renal arachidonic acid metabolism.Am J Med. 1986 Jan 17;80(1A):3-11. doi: 10.1016/0002-9343(86)90927-7. Am J Med. 1986. PMID: 3080877 Review.
Cited by
-
Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants.Pediatr Nephrol. 1990 Nov;4(6):581-4. doi: 10.1007/BF00858625. Pediatr Nephrol. 1990. PMID: 2088455
-
Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion.Am J Pathol. 1992 Aug;141(2):429-39. Am J Pathol. 1992. PMID: 1323220 Free PMC article.
-
Renal effects of prostaglandins and cyclooxygenase-2 inhibitors.Electrolyte Blood Press. 2008 Jun;6(1):35-41. doi: 10.5049/EBP.2008.6.1.35. Epub 2008 Jun 30. Electrolyte Blood Press. 2008. PMID: 24459520 Free PMC article. Review.
-
Stereoselective renal effects of the loop diuretic ozolinone in the anesthetized dog.Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):660-71. doi: 10.1007/BF00170167. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7675125
-
Peptide-dependent regulation of epithelial nephron functions.Klin Wochenschr. 1989 Sep 1;67(17):852-7. doi: 10.1007/BF01717339. Klin Wochenschr. 1989. PMID: 2554056 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources